SaverOne Signs Agreement with a Leader in ADAS Vision Solutions for Collaborative Development
Globenewswire· 2025-09-09 12:30
Partnership aims to deliver an ADAS sensor fusion platform capable of detecting Vulnerable Road Users in non-line-of-sight conditions Petah Tikvah, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in developing transportation safety solutions, today announced it has signed an agreement with a global leader in vision solution technologies. The new agreement launches a collaboration on the development of advanced driver-assistance syst ...
NIP Group Announces Closing of Mining Assets Acquisition
Globenewswire· 2025-09-09 12:30
Company Expands Board with the Appointment of Two DirectorsABU DHABI, United Arab Emirates, Sept. 09, 2025 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIPG” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced the completion of its previously announced acquisition of on-rack crypto mining machines (the “Products”) with an aggregate hash rate of 3.11 EH/s from Apex Cyber Capital Limited and Prosperity Oak Holdings Limited, to which Fortune Peak Limited assigned all of its right ...
Truth Social Enhances Platform
Globenewswire· 2025-09-09 12:30
New Update Includes Premium Features for Truth+ Patriot Package Subscribers SARASOTA, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that the Company has updated the Truth Social app to add new features and enhancements to the Truth Social platform. The update adds premium features on Tr ...
Digital Brands Group Expands Partnership with Amaze to Strengthen Domestic Apparel Manufacturing
Globenewswire· 2025-09-09 12:30
New capabilities allow Amaze to produce high-quality, cost-efficient custom apparel and athleisure, supporting creators and customers amid tariff changes and rising costs NEWPORT BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, today announced an expanded partnership with Digital Brands Group, Inc. (NASDAQ: DGBI) (“Digital Brands Group”), a publicly traded company specializing in e-commerce and fashion. Throu ...
Amaze Expands Partnership with Digital Brands Group, Inc. to Strengthen Domestic Apparel Manufacturing
Globenewswire· 2025-09-09 12:30
New capabilities allow Amaze to produce high-quality, cost-efficient custom apparel and athleisure, supporting creators and customers amid tariff changes and rising costsNEWPORT BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, today announced an expanded partnership with Digital Brands Group, Inc. (NASDAQ: DGBI) (“Digital Brands Group”), a publicly traded company specializing in e-commerce and fashion. Throug ...
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
Globenewswire· 2025-09-09 12:30
- Transaction affirms the strength of Elutia’s proprietary drug-eluting biologics platform and fully funds advancement of NXT-41 in breast reconstruction - - Company to provide update at the H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10 at 9:30 a.m. ET - GAITHERSBURG, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced it has entered into a definitive agreement ...
Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
Globenewswire· 2025-09-09 12:30
The latest AI-powered feature in Counterpart Assistant streamlines documentation, enhances physician workflows, and raises the bar for value-based care across practice settings at no additional cost to usersSAN FRANCISCO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI‑powered physician‑enablement platform, today announced a major upgrade to ...
Magnite Acquires streamr.ai to Unlock Small Business Advertising Spend for CTV Publishers
Globenewswire· 2025-09-09 12:30
Company to offer streamr.ai’s tech to its ecosystem partners for their SMB clientsNEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced the acquisition of streamr.ai, a platform specializing in AI tools that make Connected Television (CTV) advertising accessible to Small and Medium-sized Businesses (SMBs)—a large and growing revenue opportunity for CTV publishers. Magnite will offer streamr.ai’s technology to its ecosystem ...
ZenaTech Signs Offer to Acquire a Warehouse and Inventory Management Company with Established Long-Term US Defense Government Contracts, Accelerating DaaS Expansion on the East Coast
Globenewswire· 2025-09-09 12:30
VANCOUVER, British Columbia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces that it has signed an offer to acquire a Southeast US-based warehouse and inventory management services company serving a principal service branch of the US Department of Defense. With over 25 years of ...
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Globenewswire· 2025-09-09 12:30
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New therapeutic options for people living with MSA, a rare and devastating neurodegenerative disorder, are urgently needed as there are no treatments available that impact disease progression.Emrusolmin is a small molecule that targets the alpha synuclein protein, which is believed to be pivotally involved in the pat ...